These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10446316)

  • 1. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist.
    Iida M; Miyazaki I; Tanaka K; Kabuto H; Iwata-Ichikawa E; Ogawa N
    Brain Res; 1999 Aug; 838(1-2):51-9. PubMed ID: 10446316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals.
    Yoshioka M; Tanaka Ki; Miyazaki I; Fujita N; Higashi Y; Asanuma M; Ogawa N
    Neurosci Res; 2002 Jul; 43(3):259-67. PubMed ID: 12103444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist.
    Tanaka K; Miyazaki I; Fujita N; Haque ME; Asanuma M; Ogawa N
    Neurochem Res; 2001 Jan; 26(1):31-6. PubMed ID: 11358279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT
    Neurochem Res; 2011 Dec; 36(12):2244-9. PubMed ID: 21769642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum.
    Kabuto H; Nishizawa M; Tada M; Higashio C; Shishibori T; Kohno M
    Neurochem Res; 2005 Mar; 30(3):325-32. PubMed ID: 16018576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum.
    Kabuto H; Tada M; Kohno M
    Biol Pharm Bull; 2007 Mar; 30(3):423-7. PubMed ID: 17329831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages.
    Ogawa N
    Eur Neurol; 1994; 34 Suppl 3():20-8. PubMed ID: 7821332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pergolide scavenges both hydroxyl and nitric oxide free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain.
    Gómez-Vargas M; Nishibayashi-Asanuma S; Asanuma M; Kondo Y; Iwata E; Ogawa N
    Brain Res; 1998 Apr; 790(1-2):202-8. PubMed ID: 9593894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model.
    Kabuto H; Yamanushi TT; Janjua N; Takayama F; Mankura M
    J Oleo Sci; 2013; 62(1):21-8. PubMed ID: 23357814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic D
    Tremblay M; Silveira MM; Kaur S; Hosking JG; Adams WK; Baunez C; Winstanley CA
    Eur J Neurosci; 2017 Jan; 45(1):159-166. PubMed ID: 27422144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiparkinson drug ropinirole inhibits movement in a Parkinson's disease mouse model with residual dopamine neurons.
    Wang Y; Bouabid S; Darvas M; Zhou FM
    Exp Neurol; 2020 Nov; 333():113427. PubMed ID: 32735872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are dopamine receptor agonists neuroprotective in Parkinson's disease?
    Le WD; Jankovic J
    Drugs Aging; 2001; 18(6):389-96. PubMed ID: 11419913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection.
    Le WD; Jankovic J; Xie W; Appel SH
    J Neural Transm (Vienna); 2000; 107(10):1165-73. PubMed ID: 11129106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum.
    Tanaka K; Yoshioka M; Miyazaki I; Fujita N; Ogawa N
    Neurosci Lett; 2002 Mar; 321(1-2):45-8. PubMed ID: 11872253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL; Watts RL; Stoessl AJ; Davis M; Reske S; Nahmias C; Lang AE; Rascol O; Ribeiro MJ; Remy P; Poewe WH; Hauser RA; Brooks DJ;
    Ann Neurol; 2003 Jul; 54(1):93-101. PubMed ID: 12838524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
    Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
    Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroprotective effect of dopamine agonists].
    Szczudlik A; Rudzińska M
    Neurol Neurochir Pol; 2007; 41(2 Suppl 1):S22-8. PubMed ID: 17941455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-512, a novel dopamine D
    Lindenbach D; Das B; Conti MM; Meadows SM; Dutta AK; Bishop C
    Br J Pharmacol; 2017 Sep; 174(18):3058-3071. PubMed ID: 28667675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.